Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab.
Ann Lab Med
; 43(1): 96-99, 2023 01 01.
Article
in En
| MEDLINE
| ID: mdl-36045063
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Hemophilia A
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Ann Lab Med
Year:
2023
Document type:
Article